JACOBS LEVY EQUITY MANAGEMENT, INC

Position in NVCR — NovoCure Ltd

CIK 884414 FLORHAM PARK, NJ

Position in NVCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,513,262

-$1,309,890 QoQ

Shares Held

1,331,492

+8.8% QoQ

Ownership

1.15%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 76.82577139028999.ToString("F0")% Shared 0.ToString("F0")% None 23.17422860971001.ToString("F0")%

Healthcare · as of Mar 31, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $414,686,594 across 24 Medical Devices names. NVCR ranks #4 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EW	Edwards Lifesciences Corp	2,932,796	$234,858,303
2	GEHC	GE HealthCare Technologies Inc.	1,287,686	$91,657,489
3	TNDM	Tandem Diabetes Care Inc	1,523,946	$29,214,044
4	NVCR	NovoCure Ltd This page	1,331,492	$14,513,262
5	AXGN	Axogen, Inc.	384,654	$12,743,587
6	RXST	RxSight, Inc.	1,066,321	$6,568,537
7	ITGR	Integer Holdings Corp	64,635	$5,687,880
8	VREX	Varex Imaging Corp	519,137	$5,508,043

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,513,262	1,331,492	+8.8%	Shares	Sole	2026-05-15
2025-12-31	$15,823,152	1,223,755	+1093.2%	Shares	Sole	2026-02-13
2025-09-30	$1,325,113	102,563	-30.8%	Shares	Sole	2025-11-17
2025-06-30	$2,637,977	148,201	-68.8%	Shares	Sole	2025-08-14
2024-03-31	$7,427,782	475,226	+305.6%	Shares	Sole	2024-05-15
2023-12-31	$1,749,258	117,164	+433.5%	Shares	Sole	2024-02-14
2023-09-30	$354,686	21,962	-89.5%	Shares	Sole	2023-11-17
2021-03-31	$27,653,509	209,211	+14.9%	Shares	Sole	2021-05-17
2020-12-31	$31,493,626	182,002	+139.1%	Shares	Sole	2021-02-16
2020-09-30	$8,471,804	76,110	-11.6%	Shares	Sole	2020-11-16
2020-06-30	$5,105,730	86,100	+76.2%	Shares	Sole	2020-08-17
2020-03-31	$3,289,895	48,855	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.